• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

cystic fibrosis

  1. Proteostasis Therapeutics stock reached double digits

    After announcing positive results for the treatment of cystic fibrosis, Proteostasis Therapeutics stock skyrocketed more than 400% and reached the double-digit mark after 18 months. https://news.alphastreet.com/proteostasis-therapeutics-stock-skyrockets-on-positive-cystic-fibrosis-trial-results/
    • anonymous
    • Thread
    • astrazeneca biotech clinical trials cystic fibrosis fda novartis pharma proteostasis therapeutics vertex
    • Replies: 0
    • Forum: Pharma/Biotech Companies - In the News

  2. Vertex CF Portfolio Led To FY17 Expenses Forecast Lift

    $VRTX Vertex's cystic fibrosis portfolio progression has led the company to increase its guidance of combined R&D and SG&A for the full year 2017.
    • Mark Benson
    • Thread
    • cystic fibrosis earnings expenses guidance vertex
    • Replies: 0
    • Forum: Vertex
Top Bottom
Back